Delivery Order SPE2DR25D2005-SPE2DR26FE6Q9
- Not listed
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 14, 2025, provides for the supply of AMLOD-VALSA-HCTZ 5-160-12.5 mg pharmaceutical products in a 30-count package, with a ceiling value of $2,196.72 and an ultimate completion date of July 15, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. Performance will be conducted at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies under contract 4569914827, valued at $1,024.14 with a firm fixed price structure. The specific delivery involves AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a combination antihypertensive medication, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in...
- This delivery order, valued at $1,328.82, was awarded on July 31, 2025, to AmerisourceBergen Drug Corp for the supply of AMLOD-VALSA-HCTZ 10-160-12.5MG medication in 30-unit quantities. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This award is structured as a firm fixed-price delivery order with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $2,250.91 on October 27, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 mg pharmaceutical product in a 30-count package. The order, which is not set aside for any particular business category, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a $3,745.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order was placed against the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a...
- The Defense Logistics Agency awarded a delivery order valued at $3,401.50 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no...
- The Defense Logistics Agency awarded a $1,715.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-160-12.5MG 30S pharmaceutical products, with an ultimate completion date of October 24, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $11,424.98 to AmerisourceBergen Drug Corp for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 mg tablets in a 30-count quantity. This competitive, non-set-aside award was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order structure reflects the...
- The Defense Logistics Agency awarded a $1,337.76 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG in a 30-count package. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6Q9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products under contract number 4569986643, with an award date of November 12, 2025, and a ceiling value of $3,987.86. The specific delivery consists of AMLOD-VALSA-HCTZ 5-160-12.5 mg tablets (30-count supply), a combination antihypertensive medication used to treat high blood pressure. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger pharmaceutical supply contract vehicle. The place of performance is AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's substantial federal pharmaceutical portfolio and demonstrated capability to meet competitive procurement requirements through this prime contract make it a critical vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/12/25 |